Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Agendia
With
Osaka General Medical Center
Frozen tumor samples from 140 node-negative, breast cancer patients aged between 29 and 70 years at diagnosis are hybridized on MammaPrint array. Patients were treated with breast conserving therapy or mastectomy with axillary lymph node dissection between December 1998 and August 2001 at Osaka Medical Center for Cancer and Cardiovascular Diseases. Samples are evaluated by gene expression profiling for the 70-gene MammaPrint profile and classified as genomic high risk or genomic low risk.
Age
29–70
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Breast cancer patients
Node-negative
Treated with breast conserving therapy or mastectomy with axillary lymph node dissection at Osaka Medical Center for Cancer and Cardiovascular Diseases
